Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 62, 241-244
- https://doi.org/10.1007/978-1-4615-3518-8_28
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremitiesThe American Journal of Surgery, 1988
- Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1‐phenylalanine mustardJournal of Surgical Oncology, 1987
- Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomyThe American Journal of Surgery, 1986
- Toxicity and complications of vascular isolation and hyperthermic perfusion with lmidazole carboxamide (DTIC) in melanomaCancer, 1986
- Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studiesCancer, 1983
- The Treatment of Stage I Melanoma of the Extremities with Regional Hyperthermic Isolation PerfusionAnnals of Surgery, 1982
- Liposarcoma of the legThe American Journal of Surgery, 1982
- Chemotherapy of CancerAnnals of Surgery, 1958